Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis

Background: Suboptimal drug exposure in patients with drug-susceptible tuberculosis (DS-TB) can drive treatment failure. Pharmacodynamics (PD) biomarkers such as the plasma TB drug-activity (TDA) assay may guide dose finding studies and predict microbiological outcomes differently than conventional...

Полное описание

Библиографические подробности

Главные авторы:	Bibie N Said, Scott K Heysell, Getnet Yimer, Rob E Aarnoutse, Gibson S Kibiki, Stellah Mpagama, Peter M Mbelele
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wolters Kluwer Medknow Publications 2021-01-01
Серии:	International Journal of Mycobacteriology
Предметы:	mycobacterial activity pharmacodynamic biomarkers tuberculosis tuberculosis drug activity
Online-ссылка:	http://www.ijmyco.org/article.asp?issn=2212-5531;year=2021;volume=10;issue=4;spage=457;epage=462;aulast=Said
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!